Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 715

2.

Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).

Prevots DR, Burr RK, Sutter RW, Murphy TV; Advisory Committee on Immunization Practices.

MMWR Recomm Rep. 2000 May 9;49(RR-5):1-22; quiz CE1-7.

3.
5.

Paralytic poliomyelitis--United States, 1980-1994.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1997 Jan 31;46(4):79-83.

6.

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW.

JAMA. 2004 Oct 13;292(14):1696-701.

PMID:
15479934
7.

Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.

Marin M, Patel M, Oberste S, Pallansch MA.

MMWR Morb Mortal Wkly Rep. 2017 Jan 13;66(1):23-25. doi: 10.15585/mmwr.mm6601a6.

8.

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.

O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA; Chilean IPV/bOPV study group.

Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26. Erratum in: Lancet Infect Dis. 2015 Oct;15(10):1130.

PMID:
26318714
10.

Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).

Alexander L, Birkhead G, Guerra F, Helms C, Hinman A, Katz S, LeBaron CW, Modlin J, Murphy TV; National Vaccine Advisory Committee-Advisory Committee on Immunization Practices Joint Working Group; Centers for Disease Control and Prevention.

Arch Pediatr Adolesc Med. 2004 Dec;158(12):1106-12. Review.

PMID:
15583093
12.

Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.

Domingues CM, de Fátima Pereira S, Cunha Marreiros AC, Menezes N, Flannery B.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S143-51. doi: 10.1093/infdis/jit588.

13.

Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1998 Dec 4;47(47):1017-9.

14.

Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.

Khan MM, Sharma S, Tripathi B, Alvarez FP.

Public Health. 2017 Jan;142:31-38. doi: 10.1016/j.puhe.2016.10.016. Epub 2016 Nov 17.

PMID:
28057194
15.

Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.

[No authors listed]

Wkly Epidemiol Rec. 2003 Jul 11;78(28):241-50. English, French.

PMID:
15571166
17.

Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.

Li R, Li CG, Li Y, Liu Y, Zhao H, Chen X, Kuriyakose S, Van Der Meeren O, Hardt K, Hezareh M, Roy-Ghanta S.

Vaccine. 2016 Mar 14;34(12):1436-43. doi: 10.1016/j.vaccine.2016.02.010. Epub 2016 Feb 9.

20.

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.

Miller MA, Sutter RW, Strebel PM, Hadler SC.

JAMA. 1996 Sep 25;276(12):967-71.

PMID:
8805731

Supplemental Content

Support Center